Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
Follow VEEV
Veeva Systems Inc. (VEEV) EPS (diluted)
Veeva Systems Inc.'s EPS (diluted) for fiscal 2026 was $5.44, up 25.9% from $4.32 in fiscal 2025. Over the twelve months to 31 July 2026 it was $6.08. Over the past ten years it has ranged from $0.28 (fiscal 2015) to $5.44 (fiscal 2026) — the current reading is the highest in ten years. EPS (diluted) has risen for 11 consecutive fiscal years. Veeva Systems Inc. ranks 3rd of 49 Health Information Services companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2026 | $5.44 | 25.93% |
| FY2025 | $4.32 | 34.16% |
| FY2024 | $3.22 | 7.33% |
| FY2023 | $3.00 | 14.07% |
| FY2022 | $2.63 | 11.44% |
| FY2021 | $2.36 | 24.21% |
| FY2020 | $1.90 | 29.25% |
| FY2019 | $1.47 | 59.78% |
| FY2018 | $0.92 | 95.74% |
| FY2017 | $0.47 | 23.68% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jul 2026 | $1.66 | 5.73% |
| Apr 2026 | $1.57 | 8.28% |
| Jan 2026 | $1.45 | 3.57% |
| Oct 2025 | $1.40 | 17.65% |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| VEEV Veeva Systems Inc. | $6.08 |
| HQY HealthEquity, Inc. compare | $2.77 |
| BTSG BrightSpring Health Services, Inc. compare | $1.66 |
| HNGE Hinge Health Inc. compare | $1.28 |
| DOCS Doximity, Inc. compare | $0.85 |
| WAY Waystar Holding Corp. compare | $0.70 |
| TXG 10x Genomics compare | −$0.59 |
| TEM Tempus AI, Inc. compare | −$1.44 |
| HTFL Heartflow, Inc. compare | −$1.83 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on VEEV
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement